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Abstract. 
Myoepithelial carcinoma (malignant myoepithelioma) (MC) is a rare tumor, defined as a 
malignant salivary neoplasm composed almost exclusively of tumor cells with myoepithelial 
differentiation. It can arise in unusual location sites, such as the nasopharynx, and may be dif-
ficult to approach. Nasopharyngeal MC can sometimes present as a nasopharyngeal mass which 
may be mistaken for primary nasopharyngeal carcinoma (NPC). The treatment strategy for na-
sopharyngeal MC is different from NPC, and maximal surgical resection of the main lesion is 
still considered as the mainstay of therapy. Herein we present a 32-year-old man with a naso-
pharyngeal mass which was initially mistaken as NPC, and which was later confirmed as MC 
after a comprehensive review of the pathology. 
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中文摘要 
  肌上皮癌（惡性肌上皮瘤）是一種罕見的腫瘤，其定義為惡性唾液腺腫瘤合併所有
癌細胞幾乎皆具有肌上皮分化。它可以出現在不尋常的位置，例如鼻咽，而這使得它們
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可能很難被探究。鼻咽肌上皮癌有時可表現為鼻咽部的腫塊病灶，因而可能被誤認為原
發性鼻咽癌。鼻咽肌上皮癌的治療不同於鼻咽癌，儘可能地手術切除主要病變仍被認為
是主要的治療方式。這裡，我們提出一個 32 歲的男性罕見個案，有鼻咽腫塊，起初，被
臆斷為鼻咽癌；然而，在病理切片的審查複閱後，鼻咽肌上皮癌的診斷才被確立。 
 
關鍵字: 肌上皮癌、鼻咽 
 
INTRODUCTION 
Myoepithelial carcinoma (malignant myoepithe-
lioma) (MC) is defined as a malignant salivary neo-
plasm composed almost exclusively of tumor cells 
with myoepithelial differentiation [1]. It is a rarely 
occurring tumor with a reported incidence of 0.2% of 
all salivary gland tumors [2]. Most reported cases of 
MCs arise in the parotid gland (48-75%), followed by 
the minor salivary glands (reported sites include the 
palate, cheek, gum, nasal cavity, maxillary sinus, na-
sopharynx, infratemporal fossa, oral cavity, base of 
tongue, supraglottic larynx), and the submandibular 
gland [3-10]. Herein, we reported the rare case of na-
sopharyngeal MC with initial presentation of naso-
pharyngeal mass which mimicked nasopharyngeal 
carcinoma (NPC). 
 
CASE REPORT 
A 32-year-old master sergeant presented to our fa-
cility complaining of neck stiffness and shoulders pain 
for the last six months. Three months later, magnetic 
resonance (MR) imaging of the cervical spine re-
vealed a subcutaneous nodule in the level VB of the 
neck (Figure 1A). He thereafter developed tinnitus, 
blood-tinged nasal discharge and headache five 
months later and visited our hospital again. The pa-
thology of the neck nodule excisional biopsy showed 
metastatic carcinoma. During hospitalization, MR 
imaging of the neck revealed tumor infiltration of the 
nasopharyngeal mucosal space with extension to the 
bilateral petrous apex and clivus and necrotic meta-
static nodes in the bilateral level II of neck (Figures 
1B, 1C, 1D). The patient’s nasopharyngeal mass pa-
thology revealed a poorly differentiated carcinoma. 
Therefore, advanced NPC, cT4N2M1, stage IV was 
preliminarily diagnosed. He underwent concurrent 
chemoradiotherapy (CCRT) with weekly cisplatin 
after the diagnosis. However, his symptoms became 
worse despite the ongoing treatment.  
We reviewed the pathology of the patient’s biop-
sies in the multidisciplinary team meeting. Micro-
scopically, the tumor cells had polymorphous patterns 
with enlarged, pleomorphic nuclei with distinct nucle-
oli as well as eosinophilic or vacuolated cytoplasm 
arranged in sheet-like and reticular patterns infiltrating 
in both neck and nasopharyngeal tissue (Figures 2A, 
2B). The immunohistochemical (IHC) staining 
showed immunoreactive for epithelial cell markers, 
including cytokeratin and epithelial membrane antigen 
(EMA) (Figure 2C), and myoepithelial markers, in-
cluding smooth muscle actin (SMA), S-100 (Figure 
2D), calponin, glial fibrillary acidic protein (GFAP) 
and p63. The diagnosis of nasopharyngeal MC was 
revised one month later after initial approach, but an 
intensive therapeutic strategy with combined modali-
ties using maximal surgical resection and radiotherapy 
(RT) [11,12] was not feasible because of his poor per-
formance status. The patient received palliative 
chemotherapeutic regimens with tri-weekly doxorubi-
cin plus cisplatin and tri-weekly docetexal after the 
CCRT. Poor response was noted and the patient exhib-
ited an intolerance to chemotherapy. Supportive med- 
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Figure 1. (A) T2-weighted MR imaging of the C-spine revealed an 1.2-cm metastatic nodule in the level VB of 
the neck (arrow). (B, C, D) Post-contrast T1-weighted MR imaging of the nasopharynx showed tumor 
infiltration in the nasopharyngeal mucosal space on both sides (arrows in B) with extension to the bilat-
eral petrous apex (arrows in C) and clivus (arrowhead in C) and necrotic metastatic nodes in the bilat-
eral level II of the neck (arrows in D) 
 
 
ical treatment was given thereafter. He died of the 
disease eight months after the disease diagnosis. 
 
 
DISCUSSION 
MCs are tumors of epithelial origin that may occur 
with preexisting benign lesions like pleomorphic ade-
nomas or benign myoepitheliomas, but they can also  
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Figure 2. The pathological exams of the metastatic nodule (2A) and the primary lesion (2B) revealed similar find-
ings. Tumor cells have polymorphous patterns with enlarged, pleomorphic nuclei with distinct nucleoli as 
well as eosinophilic or vacuolated cytoplasm arranged in sheet-like and reticular patterns infiltrating in 
both neck and nasopharyngeal tissue (H&E, 400X). The immunohistochemistry (IHC) staining showed 
positive for (C) epithelial membrane antigen (EMA, 200X) and (D) S100 (200X). (IHC was done using 
diaminobenzidine substrate and the brown color indicated expression of staining.) 
 
 
occur de novo [13]. These tumors usually present as 
painless masses with insidious onset. When MCs oc-
cur in the nasopharynx, the symptoms are the same as 
those of other tumors that affect this region, such as 
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nasal obstruction, ear fullness, serous otitis media, and 
conductive hearing loss. There is also a lack of diag-
nostic criteria. On account of the aforementioned rea-
sons, early detection is difficult and the diagnosis may 
be delayed by months or even years.  
Computed tomography (CT) and MR imaging al-
low the site and the nature of the extension of MCs to 
be established. However, some MCs may appear 
non-invasive and could be mistaken as benign on im-
aging alone. In the past, very few reports have de-
scribed imaging findings of MCs. Martinoli et al. re-
ported nonspecific CT features of the MCs arising in 
salivary tissue on the masseter muscle [14]. In general, 
MCs appear isodense to muscle and moderate ho-
mogenous contrast enhancement on CT images. On 
MR images, MCs typically show low to intermediate 
signal intensities on T1-weighted images and hetero-
geneously increased signal intensities on T2-weighted 
images with a tendency to invade adjacent structures 
[8, 15]. In our case, the preoperative imaging findings 
were nonspecific and the impression was advanced 
NPC with metastatic nodes in the neck. 
Due to the nonspecific clinical manifestation and 
imaging characteristics, preoperative diagnosis may be 
difficult or impossible for MCs. Histological examina-
tion with IHC staining studies is the most reliable and 
conclusive method of diagnosis. Histologically, MCs 
are characterized by multilobulated architectures 
without ductal formation and have myoepithelial dif-
ferentiation. Morphologically, the tumor cells are of-
ten spindle-shaped, stellate, epithelioid, plasmacytoid 
(hyaline), and occasionally vacuolated with a signet 
ring-like appearance. Solid sheet-like formations and 
trabecular or reticular patterns (biphasic pattern) may 
form by tumor cells [16]. The presence of significant 
atypia, atypical mitotic figure, hemorrhage, and ne-
crosis have been considered features of malignancy 
[17]. IHC analysis shows elevated expression of epi-
thelial markers such as CK, EMA, S-100, and markers 
of smooth muscle origin such as SMA and calponin on 
the tumor cells of MCs. Current IHC criteria for the 
confirmation of myoepithelial differentiation are dou-
ble positive for both CK and one or more myoepithe-
lial IHC markers (i.e., S-100, vimentin, calponin, p63, 
GFAP, and actins) [18-21]. There are still some tumors 
that also show similar spindle cell composition, such 
as parachordoma, chordoma, extraskeletal myxoid 
chondrosarcoma, unusual carcinoma and even chon-
drosarcoma if a chondroid matrix is present and the 
sampling is small. Therefore, IHC studies are useful 
and the expression patterns may help us to distinguish 
MCs from other tumors. 
Brandal et al. found that t(19;22)(q13;q12) trans-
location leads to a novel fusion gene, EWSR1- 
ZNF444. The significance of this new fusion gene to 
tumorigenesis is not clearly understood, but it may be 
a defining pathogenetic feature of some of these tu-
mors [22]. In dedifferentiated MCs, nuclear accumu-
lation of p53 and cyclin D1 has been described [23,24], 
and a recent article also showed an expression of 
platelet-derived growth factor A (PDGFA) genes in 
the tumor [25]. However, due to the limited number of 
patients that have been studied, the clinical applicabil-
ity of this earlier investigation requires further inquiry.  
Interestingly, MCs usually exhibit a propensity for 
distant metastasis more than for regional lymph node 
metastasis [7]. Distant metastasis has been seen to the 
lungs (most commonly), bone, liver, peritoneum, 
pleura, kidneys, brain, and skin in previous reports 
[4,11,26]. Unlike certain nasopharyngeal tumors for 
which CCRT are the preferred treatments in some 
cases, the application of these treatments to nasopha-
ryngeal MCs has been disappointing. However, there 
are no specific guidelines for the treatment of MCs, 
especially in the uncommon sites. In general, com-
plete resection with tumor-free margin remains the 
first choice of treatment for nasopharyngeal MCs. In 
addition, local radiotherapy or chemotherapy may be 
the most effective adjuvant strategy for the patients. 
     
CONCLUSIONS 
Nasopharyngeal MC is a rare entity, but often ob-
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served as having a very aggressive characteristic. It 
can sometimes present as a nasopharyngeal mass 
which may be mistaken for primary NPC. If accurate-
ly diagnosed, an intensive therapeutic strategy with 
combined modalities may provide the best chance of 
long-term control. 
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